Maria C Athanasiou

Summary

Affiliation: Genaissance Pharmaceuticals
Country: USA

Publications

  1. ncbi request reprint Discovery and utilization of haplotypes for pharmacogenetic studies of psychotropic drug response
    Maria C Athanasiou
    Genaissance Pharmaceuticals, Inc, New Haven, Connecticut 06511, USA
    Psychiatr Genet 12:89-96. 2002
  2. doi request reprint The role of pharmacogenetics in treating central nervous system disorders
    Meeta Patnaik
    PGxHealth, LLC, A Division of Clinical Data, Inc, NASDAQ CLDA, 5 Science Park, New Haven, CT 06511, USA
    Exp Biol Med (Maywood) 233:1504-9. 2008

Collaborators

Detail Information

Publications2

  1. ncbi request reprint Discovery and utilization of haplotypes for pharmacogenetic studies of psychotropic drug response
    Maria C Athanasiou
    Genaissance Pharmaceuticals, Inc, New Haven, Connecticut 06511, USA
    Psychiatr Genet 12:89-96. 2002
    ..This approach has clear implications for the discovery of psychiatric disease-associated genes as well as for the development of safer, more efficacious psychiatric drugs...
  2. doi request reprint The role of pharmacogenetics in treating central nervous system disorders
    Meeta Patnaik
    PGxHealth, LLC, A Division of Clinical Data, Inc, NASDAQ CLDA, 5 Science Park, New Haven, CT 06511, USA
    Exp Biol Med (Maywood) 233:1504-9. 2008
    ..The intent of this review is to highlight the power of PGx testing to predict the likelihood of ADRs and efficacy during the treatment of the following CNS disorders: epilepsy, bipolar disorder, schizophrenia and depression...